King Wealth Amgen Inc Transaction History

King Wealth

$570 Million
Q1 2024

A detailed history of King Wealth transactions in Amgen Inc stock. As of the latest transaction made, King Wealth holds 6,682 shares of AMGN stock, worth $2.08 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

6,682

Previous 6,982 4.3%

Holding current value

$2.08 Million

Previous $2.01 Million 5.52%

% of portfolio

0.33%

Previous 0.39%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $80,661 - $97,368	-300 Reduced 4.3%	6,682 $1.9 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $120,946 - $136,441	-473 Reduced 6.34%	6,982 $2.01 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $44,823 - $55,649	-205 Reduced 2.68%	7,455 $2 Million
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $146,989 - $173,811	686 Added 9.84%	7,660 $1.7 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $437,355 - $533,062	1,937 Added 38.46%	6,974 $1.69 Million

Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $448,898 - $570,379	-1,960 Reduced 28.01%	5,037 $1.32 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $41,974 - $47,339	187 Added 2.75%	6,997 $1.58 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $56,293 - $62,644	-244 Reduced 3.46%	6,810 $1.66 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $28,943 - $32,019	132 Added 1.91%	7,054 $1.71 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $47,333 - $54,168	238 Added 3.56%	6,922 $1.56 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $4,669 - $5,471	22 Added 0.33%	6,684 $1.42 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $685,790 - $760,835	-2,936 Reduced 30.59%	6,662 $1.62 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $5,769 - $6,723	-26 Reduced 0.27%	9,598 $2.39 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $1.26 Million - $1.5 Million	5,810 Added 152.33%	9,624 $2.21 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $257,411 - $286,262	1,097 Added 40.38%	3,814 $969,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $197,612 - $242,497	-999 Reduced 26.88%	2,717 $641,000
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $299,602 - $397,354	1,644 Added 79.34%	3,716 $753,000
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $94,794 - $121,843	501 Added 31.89%	2,072 $499,000
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $273,526 - $327,742	1,571 New	1,571 $304,000
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $286,057 - $335,323	-1,716 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $361 - $407	2 Added 0.12%	1,716 $326,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $67,078 - $78,302	376 Added 28.1%	1,714 $334,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $5,373 - $6,057	29 Added 2.22%	1,338 $277,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $7,638 - $8,579	46 Added 3.64%	1,309 $242,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $8,302 - $9,702	-49 Reduced 3.73%	1,263 $215,000
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $8,270 - $9,240	-49 Reduced 3.6%	1,312 $228,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $167 - $191	1 Added 0.07%	1,361 $254,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,360	1,360 $234,000

Others Institutions Holding AMGN

# of Institutions

2,932

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

News

Stay updated on King Wealth with notifications on news.

Account